Literature DB >> 22704445

Systemic buffers inhibit carcinogenesis in TRAMP mice.

Arig Ibrahim-Hashim1, Heather H Cornnell, Dominique Abrahams, Mark Lloyd, Marilyn Bui, Robert J Gillies, Robert A Gatenby.   

Abstract

PURPOSE: Hypoxia and acidosis develop in in situ tumors as cellular expansion increases the diffusion distance of substrates and metabolites from blood vessels deep to the basement membrane. Prior studies of breast and cervical cancer revealed that cellular adaptation to microenvironmental hypoxia and acidosis is associated with the transition from in situ to invasive cancer. We hypothesized that decreased acidosis in intraductal tumors would alter environmental selection pressures for acid adapted phenotypes and delay or prevent evolution to invasive cancer.
MATERIALS AND METHODS: A total of 37 C57BL/6 TRAMP mice were randomized to a control group or to 1 of 4 treatment groups. In the latter groups 200 mM sodium bicarbonate were added to drinking water starting between ages 4 and 10 weeks.
RESULTS: In all 18 controls prostate cancer developed that was visible on 3-dimensional ultrasound at a mean age of 13 weeks. They died within 52 weeks (median 37). When sodium bicarbonate therapy commenced before age 6 weeks in 10 mice, all reached senescence (age 76 weeks) without radiographic evidence of prostate cancer. Histological sections of the prostates in this cohort showed hyperplasia but no cancer in 70% of mice and minimal well differentiated cancer in the remainder. When therapy commenced after age 6 weeks in 9 mice, prostate cancer development was no different from that in controls.
CONCLUSIONS: Immunohistochemical staining for carbonic anhydrase 9 in regions of ductal hyperplasia showed increased expression in controls vs the early treatment group. Regional pH perturbation in in situ tumors may be a simple, inexpensive and effective cancer prevention strategy.
Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22704445      PMCID: PMC3694604          DOI: 10.1016/j.juro.2012.03.113

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  27 in total

1.  Metabolic changes during carcinogenesis: potential impact on invasiveness.

Authors:  Kieran Smallbone; Robert A Gatenby; Robert J Gillies; Philip K Maini; David J Gavaghan
Journal:  J Theor Biol       Date:  2006-09-16       Impact factor: 2.691

Review 2.  The evolutionary mechanism of cancer.

Authors:  Henry H Q Heng; Joshua B Stevens; Steven W Bremer; Karen J Ye; Guo Liu; Christine J Ye
Journal:  J Cell Biochem       Date:  2010-04-15       Impact factor: 4.429

Review 3.  The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis.

Authors:  Rosa A Cardone; Valeria Casavola; Stephan J Reshkin
Journal:  Nat Rev Cancer       Date:  2005-10       Impact factor: 60.716

4.  Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors.

Authors:  Jason C Morris; Johanna Chiche; Caroline Grellier; Marie Lopez; Laurent F Bornaghi; Alfonso Maresca; Claudiu T Supuran; Jacques Pouysségur; Sally-Ann Poulsen
Journal:  J Med Chem       Date:  2011-09-02       Impact factor: 7.446

5.  Acid pH in tumors and its potential for therapeutic exploitation.

Authors:  I F Tannock; D Rotin
Journal:  Cancer Res       Date:  1989-08-15       Impact factor: 12.701

Review 6.  Why do cancers have high aerobic glycolysis?

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

7.  Bicarbonate increases tumor pH and inhibits spontaneous metastases.

Authors:  Ian F Robey; Brenda K Baggett; Nathaniel D Kirkpatrick; Denise J Roe; Julie Dosescu; Bonnie F Sloane; Arig Ibrahim Hashim; David L Morse; Natarajan Raghunand; Robert A Gatenby; Robert J Gillies
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

Review 8.  A microenvironmental model of carcinogenesis.

Authors:  Robert A Gatenby; Robert J Gillies
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

9.  Genistein chemoprevention of prostate cancer in TRAMP mice.

Authors:  Jun Wang; Isam-Eldin Eltoum; Coral A Lamartiniere
Journal:  J Carcinog       Date:  2007-03-16

10.  Genetic progression and the waiting time to cancer.

Authors:  Niko Beerenwinkel; Tibor Antal; David Dingli; Arne Traulsen; Kenneth W Kinzler; Victor E Velculescu; Bert Vogelstein; Martin A Nowak
Journal:  PLoS Comput Biol       Date:  2007-11       Impact factor: 4.475

View more
  64 in total

1.  Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes.

Authors:  Mark Robertson-Tessi; Robert J Gillies; Robert A Gatenby; Alexander R A Anderson
Journal:  Cancer Res       Date:  2015-04-15       Impact factor: 12.701

Review 2.  The Evolution and Ecology of Resistance in Cancer Therapy.

Authors:  Robert Gatenby; Joel Brown
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

Review 3.  Acidosis and cancer: from mechanism to neutralization.

Authors:  Arig Ibrahim-Hashim; Veronica Estrella
Journal:  Cancer Metastasis Rev       Date:  2019-06       Impact factor: 9.264

4.  Acid-mediated tumor proteolysis: contribution of cysteine cathepsins.

Authors:  Jennifer M Rothberg; Kate M Bailey; Jonathan W Wojtkowiak; Yael Ben-Nun; Matthew Bogyo; Ekkehard Weber; Kamiar Moin; Galia Blum; Raymond R Mattingly; Robert J Gillies; Bonnie F Sloane
Journal:  Neoplasia       Date:  2013-10       Impact factor: 5.715

Review 5.  Can oncology recapitulate paleontology? Lessons from species extinctions.

Authors:  Viola Walther; Crispin T Hiley; Darryl Shibata; Charles Swanton; Paul E Turner; Carlo C Maley
Journal:  Nat Rev Clin Oncol       Date:  2015-02-17       Impact factor: 66.675

6.  Pre-treatment serum bicarbonate predicts for primary tumor control after stereotactic body radiation therapy in patients with localized non-small cell lung cancer.

Authors:  Nikhil Sebastian; Trudy Wu; Erin Driscoll; Henning Willers; Suzanne Kelly; Hima Bindu Musunuru; Xiaokui Mo; Yubo Tan; Jose Bazan; Karl Haglund; Meng Xu-Welliver; Andrew M Baschnagel; Andrew Ju; Florence Keane; Terence M Williams
Journal:  Radiother Oncol       Date:  2019-06-05       Impact factor: 6.280

Review 7.  Metabolism and its sequelae in cancer evolution and therapy.

Authors:  Robert J Gillies; Robert A Gatenby
Journal:  Cancer J       Date:  2015 Mar-Apr       Impact factor: 3.360

Review 8.  Therapies targeting cancer stem cells: Current trends and future challenges.

Authors:  Denisa L Dragu; Laura G Necula; Coralia Bleotu; Carmen C Diaconu; Mihaela Chivu-Economescu
Journal:  World J Stem Cells       Date:  2015-10-26       Impact factor: 5.326

Review 9.  Tumour acidosis: from the passenger to the driver's seat.

Authors:  Cyril Corbet; Olivier Feron
Journal:  Nat Rev Cancer       Date:  2017-09-15       Impact factor: 60.716

Review 10.  Targeting acidity in cancer and diabetes.

Authors:  Robert J Gillies; Christian Pilot; Yoshinori Marunaka; Stefano Fais
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-01-30       Impact factor: 10.680

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.